Deep Breaths: Updates from CHEST

Release Date

All Episodes

What Type 2 Inflammation in COPD Means for Treatment Decision Making

Host: Stephanie Christenson, MD Guest: Diego Maselli, MD, FCCP COPD is increasingly recognized as a heterogeneous disease, and for a subset of patients, type 2 inflammation plays a meaningful role in exacerbation risk and treatment response. Given that, Drs. Stephanie Christenson ... Show more

. 15min 0sec

Escalating COPD Care: From Flares to Long-Term Control

Guest: Ravi Kalhan, MD Guest: MeiLan K. Han, MD, MS For patients with chronic obstructive pulmonary disease (COPD), exacerbations are early indicators of disease progression—not just isolated events. In this expert-led discussion, Drs. Ravi Kalhan and Meilan Han break down the la ... Show more

. 16min 30sec

Recognizing Methamphetamine-Associated PAH: Strategies for Complex Care

Faculty: Rodolfo A. Estrada MD, FCCP Faculty: Steven M. Hollenberg, MD Faculty: Dana Kay, DO Subtle symptoms and overlooked risk factors can delay diagnosis of methamphetamine-associated pulmonary arterial hypertension (PAH), especially given regional differences in clinical prac ... Show more

. 16min 30sec

Redefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy

Guest: Gerard A. Silvestri MD, MS, Master FCCP Guest: Mariam Alexander, MD, PhD Guest: Jessica S. Donington, MD, MSCR The 2025 European Society for Medical Oncology Congress and World Conference on Lung Cancer revealed significant updates in non-small cell lung cancer care. Learn ... Show more

. 17min 15sec

Clinical Updates in Non-Small Cell Lung Cancer: From Surveillance to Treatment

Guest: Gerard A. Silvestri MD, MS, Master FCCP Guest: Adam H. Fox, MD, MSc Guest: Anurag Singh, MD, PhD From updated surveillance strategies to evolving biopsy techniques and treatment advances, recent findings presented at 2025 conferences are reshaping non-small cell lung cance ... Show more

. 18min 15sec